Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-22

Clinical Trial Update: A Safety Study Of Pregabalin In Fibromyalgia [Phase 3]

View source ↗

Summary

A Phase 3 safety study of pregabalin in fibromyalgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Fibromyalgia | Phase 3 | Status: COMPLETED